story of the week
Efficacy of Capivasertib in Combination With Fulvestrant in Patients With HR+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
N. Engl. J. Med 2023 Jun 01;388(22)2058-2070, NC Turner, M Oliveira, SJ Howell, F Dalenc, J Cortes, HL Gomez Moreno, X Hu, K Jhaveri, P Krivorotko, S Loibl, S Morales Murillo, M Okera, YH Park, J Sohn, M Toi, E Tokunaga, S Yousef, L Zhukova, EC de Bruin, L Grinsted, G Schiavon, A Foxley, HS RugoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.